A California biotech tycoon has been found guilty of orchestrating a murder-for-hire plot to kill a father of six and former business partner after their oil deal collapsed. Serhat Gumrukcu, 42, of ...

Things have started to pick up markedly in the biotech sector over the past month. The SPDR® S&P Biotech ETF (NYSEARCA:XBI) is up 9.5% over the past month, far outpacing the returns in both the S&P ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. Every year, thousands of biotech breakthroughs stall. Not because the science failed, but ...

Sutro Biopharma was once worth $1 billion, another Bay Area biotech company with deep coffers and a novel research plan. And now, like at so many of its peers, the layoffs are stacking up. After ...

A Dallas biotech company is working on something that sounds straight out of science fiction: bringing back extinct animals. The company just opened its new global headquarters in Dallas, where more ...

Despite a challenging year, the biotech industry has continued to push boundaries, taking bold risks in pursuit of groundbreaking science. If anything, this year has only strengthened our conviction ...

Shares of UniQure N.V. rose 248% on Wednesday, lifted by a successful trial of the biotech’s gene therapy for Huntington’s disease, which has also boosted shares of partner ClearPoint Neuro Inc.

ProPhase Labs Inc. (Nasdaq: PRPH), a biotech firm with plans to build a crypto treasury, announced on Sep. 23 that its three COVID-19 testing lab units have filed for reorganization under Chapter 11 ...

The volatile biotech industry has done reasonably well so far in 2025 amid the ongoing tariff saga. Most pharma/biotech bigwigs are now investing heavily in manufacturing plants/operations in the ...

JERSEY CITY, N.J.--(BUSINESS WIRE)--Character Biosciences, a precision medicine company transforming drug development for polygenic diseases, today announced that Fierce Biotech has named it as one of ...

Bob Langer, co-founder of Moderna and many other biotechnology companies, has teamed with son Michael and other healthcare-industry veterans at T.Rx Capital, a new venture firm that has raised $77.5 ...

America finds itself in a chronic-disease crisis, but not because of a shadowy cabal or a bad food pyramid. We got here because prosperity did what prosperity does: make energy cheap and work easy.